144 related articles for article (PubMed ID: 20147323)
1. Risk factors and prognosis of post-operative pneumonia due to Pseudomonas aeruginosa following cardiac surgery.
Allou N; Kermarrec N; Muller C; Thabut G; Philip I; Lucet JC; Montravers P
J Antimicrob Chemother; 2010 Apr; 65(4):806-7. PubMed ID: 20147323
[No Abstract] [Full Text] [Related]
2. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR
J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
[TBL] [Abstract][Full Text] [Related]
3. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
Khan JA; Iqbal Z; Rahman SU; Farzana K; Khan A
Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
[TBL] [Abstract][Full Text] [Related]
4. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
[No Abstract] [Full Text] [Related]
5. Outbreak of Pseudomonas aeruginosa producing IMP-9-type metallo-beta-lactamase in Guangzhou, China.
Chao Z; Xiao-Feng W; Dan-Hong S; Jin-Ping Y; Nan-Shan Z
Int J Antimicrob Agents; 2008 Oct; 32(4):363-5. PubMed ID: 18619819
[No Abstract] [Full Text] [Related]
6. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa.
Nakamura A; Miyake K; Misawa S; Kuno Y; Horii T; Kondo S; Tabe Y; Ohsaka A
J Hosp Infect; 2013 Feb; 83(2):153-5. PubMed ID: 23201400
[TBL] [Abstract][Full Text] [Related]
7. National Antimicrobial Resistance Surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005.
Dejsirilert S; Suankratay C; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N; Tantisiriwat W
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S68-75. PubMed ID: 21298847
[TBL] [Abstract][Full Text] [Related]
8. [The recent trend of multi-drug resistant Pseudomonas aeruginosa in the field of surgery].
Nakayama I; Yamaji E
Nihon Rinsho; 1991 Oct; 49(10):2373-80. PubMed ID: 1660947
[No Abstract] [Full Text] [Related]
9. Clindamycin and metronidazole as independent risk factors for nosocomial acquisition of multidrug-resistant Pseudomonas aeruginosa.
Cipriano Souza R; Vicente AC; Vieira VV; Marques SG; Soares Md; Moura MC; Koifman RJ
J Hosp Infect; 2008 Aug; 69(4):402-3. PubMed ID: 18511147
[No Abstract] [Full Text] [Related]
10. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
Matinca D; Vancea D; Boboş C; Serban O
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
[No Abstract] [Full Text] [Related]
11. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa.
Prasad SV; Ballal M; Shivananda PG
Indian J Pathol Microbiol; 2007 Jan; 50(1):94-6. PubMed ID: 17474274
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of clinical features and outcome of nosocomial pneumonia caused by Pseudomonas aeruginosa].
Baĭgozina EA
Klin Med (Mosk); 2009; 87(6):57-9. PubMed ID: 19670720
[TBL] [Abstract][Full Text] [Related]
13. [Pseudomonas aeruginosa lung infections of senior patients in intensive care unit].
Zhou JY; Fu YR; Guo QL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):733. PubMed ID: 15555410
[No Abstract] [Full Text] [Related]
14. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
Gad GF; El-Domany RA; Zaki S; Ashour HM
J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
[TBL] [Abstract][Full Text] [Related]
15. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
Tennenberg AM; Davis NB; Wu SC; Kahn J
Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum beta-lactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey.
Yakupogullari Y; Poirel L; Bernabeu S; Kizirgil A; Nordmann P
J Antimicrob Chemother; 2008 Jan; 61(1):221-2. PubMed ID: 17981831
[No Abstract] [Full Text] [Related]
17. Update on the treatment of Pseudomonas aeruginosa pneumonia.
El Solh AA; Alhajhusain A
J Antimicrob Chemother; 2009 Aug; 64(2):229-38. PubMed ID: 19520717
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa.
Tam VH; Chang KT; LaRocco MT; Schilling AN; McCauley SK; Poole K; Garey KW
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):309-14. PubMed ID: 17617302
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa infection after living-donor liver transplantation in adults.
Hashimoto M; Sugawara Y; Tamura S; Kaneko J; Matsui Y; Kokudo N; Makuuchi M
Transpl Infect Dis; 2009 Feb; 11(1):11-9. PubMed ID: 18811632
[TBL] [Abstract][Full Text] [Related]
20. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
Abdallah HB; Noomen S; Khélifa AB; Sahnoun O; Elargoubi A; Mastouri M
Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
